Clinical Roundup Phase III BOSTON study meets primary endpoint with significant increase in PFS March 06, 2020Vol.46 No.10
Clinical Roundup Keytruda meets PFS primary endpoint in phase III KEYNOTE-204 March 06, 2020Vol.46 No.10
Clinical Roundup From scorpion to immunotherapy: City of Hope scientists repurpose toxin for first-of-its kind CAR-T cell therapy for brain tumors March 06, 2020Vol.46 No.10
Clinical Roundup VBI Vaccines phase I/II study demonstrates OS benefit for VBI-1901 vaccine responders in recurrent GBM March 06, 2020Vol.46 No.10
In Brief Research!America: Republicans, Democrats should prioritize research investment March 06, 2020Vol.46 No.10
In Brief John Sampson named president of the Duke Health physician practice March 06, 2020Vol.46 No.10
